Literature DB >> 2261342

Expression of integrins in human bone marrow.

D Soligo1, R Schiró, R Luksch, G Manara, N Quirici, C Parravicini, G Lambertenghi Deliliers.   

Abstract

Expression of integrins, a superfamily of glycoprotein alpha/beta heterodimers which integrate the cytoskeleton with the extracellular matrix and/or mediate cell-cell adhesive interactions, was examined on normal and leukaemic bone marrow cells by immunohistochemistry and immunotransmission electron microscopy (immuno-TEM). Among the beta 1/VLA molecules studied, VLA-2 and 6 were expressed on megakaryocytes and platelets, while VLA-4 was present on 40% of haemopoietic cells, including monocytes, erythroblasts and immature cells; this molecule was typically localized at sites of intercellular contact, as seen by immuno-TEM, suggesting it may be involved in interactions among haemopoietic cells during differentiation. In human long-term bone marrow cultures (LTBMC), VLA-1 and 3 were present respectively on 35% and 40% of the adherent cells which included fibroblasts and endothelial cells, as shown by double-labelling experiments; VLA-2 was expressed only on a subpopulation of fibroblasts. beta 2/LeuCAM molecules were absent from platelets, megakaryocytes and HLA-DR+/myeloperoxidase- early myeloid precursors, and appeared progressively during maturation in both lymphoid and myeloid cells. Expression of beta 3/cytoadhesin molecules was restricted to megakaryocytes and platelets and, in the adherent layer of LTBMC, to endothelial cells. The regulated expression and specific localization of integrins in the bone marrow suggest that these molecules may have a role in normal haemopoiesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2261342     DOI: 10.1111/j.1365-2141.1990.tb06363.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.

Authors:  T Papayannopoulou; B Nakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

2.  Localization of beta 1 integrins and their extracellular ligands in human lymphoid tissues.

Authors:  T K van den Berg; M van der Ende; E A Döpp; G Kraal; C D Dijkstra
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 3.  Stem cell homing: rolling, crawling, and nesting.

Authors:  P J Quesenberry; P S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin.

Authors:  S H Lang; N W Clarke; N J George; N G Testa
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 5.  The extracellular matrix of the hematopoietic microenvironment.

Authors:  G Klein
Journal:  Experientia       Date:  1995-09-29

6.  Endothelial progenitor cells as factors in neovascularization and endothelial repair.

Authors:  Stefano Capobianco; Venu Chennamaneni; Mayank Mittal; Nannan Zhang; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-12-26

7.  Beta 1 integrins mediate adherent phenotype of human erythroblastic cell lines after phorbol 12-myristate 13-acetate induction.

Authors:  A Molla; R Berthier; A Chapel; A Schweitzer; A Andrieux
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

8.  Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.

Authors:  M A Reuss-Borst; H J Bühring; G Klein; C A Müller
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

9.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

Authors:  J Teixidó; M E Hemler; J S Greenberger; P Anklesaria
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

10.  Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.

Authors:  Joseph M Petty; Christopher C Lenox; Daniel J Weiss; Matthew E Poynter; Benjamin T Suratt
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.